Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis

Dolan, Sean B.; Shetty, Ritu A.; Forster, Michael J.; Gatch, Michael B.

doi:10.1177/0269881118780613

Cited by 1 publication

(1 citation statement)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The structural modifications of piperazine derivatives are also similar to the known amphetamine-derived compounds [ 18 ]. Chemically, these compounds are derived from piperazine, an organic heterocyclic compound with two nitrogen atoms in the opposite position [ 10 , 19 , 20 ]. Due to their structure, all piperazine derivatives can be divided into two groups: benzylpiperazines, e.g., N-benzylpiperazine (BZP), 1-(3,4-methylenedioxybenzyl)piperazine (MDBP), 1-(4-fluorobenzyl)piperazine (pFBP), 1,4-dibenzylpiperazine (DBZP); and phenylpiperazines, e.g., 1-(3-trifluoromethylphenyl)piperazine (TFMPP), 1-(3-chlorophenyl)piperazine (mCPP), 1-(4-parafluorophenyl)piperazine (pFPP), 1-(4-methoxyphenyl)piperazine (MeOPP).…”

Section: Introductionmentioning

confidence: 99%

Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs

Welz

Koba

Kośliński

et al. 2022

JCM

View full text Add to dashboard Cite

Recreational use of piperazine designer drugs is a serious threat to human health. These compounds act on the body in a similar fashion to illegal drugs. They induce psychostimulatory effects as well as visual and auditory hallucinations to varying degrees. In many cases of poisoning and deaths, the presence of two or even several psychoactive substances have been demonstrated. Piperazine derivatives are often found in such mixtures and pose a great analytical problem during their identification. Additionally, some piperazine derivatives can be detected in biological material as a result of metabolic changes to related drugs. Therefore, it is necessary to correctly identify these compounds and ensure repeatability of determinations. This article presents a comparison of the methods used to detect abused piperazine designer drugs using liquid chromatography in combination with a diode-array detector (LC-DAD) or mass spectrometer (LC-MS). Each of methods can be used independently for determinations, obtaining reliable results in a short time of analysis. These methods can also complement each other, providing qualitative and quantitative confirmation of results. The proposed methods provide analytical confirmation of poisoning and may be helpful in toxicological diagnostics.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs

Welz

Koba

Kośliński

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis

Abstract: These data indicate that DBZP is more similar to BZP, albeit with lower potency and efficacy, than its serotonergic piperazine counterparts, and is a behaviorally-active compound with some abuse liability and potential for adverse health effects.

Cited by 1 publication

References 47 publications

Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs

Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs

Contact Info

Product

Resources

About